BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Curated database of commensal, symbiotic and pathogenic microbiota ✅
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
|
A diet high in FODMAPs as a novel dietary strategy in diabetes? ✅
Go to Publication ✅
Clinical nutrition (Edinburgh, Scotland) (Clin Nutr ) Vol: 41 Issue 10 Pages: 2103-2112 Pub: 2022 Oct Epub: 2022 Aug 7 Authors Chu N , Chan JC , Chow E , |
|
|
Randomised clinical trial: effect of low-FODMAP rye bread versus regular rye bread on the intestinal microbiota of irritable bowel syndrome patients: association with individual symptom variation. ✅
Go to Publication ✅
BMC nutrition (BMC Nutr ) Vol: 5 Issue Pages: 12 Pub: 2019 Epub: 2019 Mar 6 Authors Laatikainen R , Jalanka J , Loponen J , Hongisto SM , Hillilä M , Koskenpato J , Korpela R , Salonen A , |
|
|
Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. ✅
Go to Publication ✅
Alimentary pharmacology & therapeutics (Aliment Pharmacol Ther ) Vol: 42 Issue 4 Pages: 418-27 Pub: 2015 Aug Epub: 2015 Jun 24 Authors Chumpitazi BP , Cope JL , Hollister EB , Tsai CM , McMeans AR , Luna RA , Versalovic J , Shulman RJ , |
|
|
Nutritional, microbiological and psychosocial implications of the low FODMAP diet. ✅
Go to Publication ✅
Journal of gastroenterology and hepatology (J Gastroenterol Hepatol ) Vol: 32 Suppl 1 Issue Pages: 16-19 Pub: 2017 Mar Epub: Authors Staudacher HM , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
